nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Jaundice cholestatic—Glyburide—type 2 diabetes mellitus	0.0108	0.0108	CcSEcCtD
Clavulanate—Jaundice cholestatic—Gliclazide—type 2 diabetes mellitus	0.00967	0.00967	CcSEcCtD
Clavulanate—Hepatitis—Acarbose—type 2 diabetes mellitus	0.00894	0.00894	CcSEcCtD
Clavulanate—Erythema multiforme—Chlorpropamide—type 2 diabetes mellitus	0.0088	0.0088	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Repaglinide—type 2 diabetes mellitus	0.00824	0.00824	CcSEcCtD
Clavulanate—Erythema multiforme—Nateglinide—type 2 diabetes mellitus	0.00815	0.00815	CcSEcCtD
Clavulanate—Leukopenia—Tolbutamide—type 2 diabetes mellitus	0.00797	0.00797	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Rosiglitazone—type 2 diabetes mellitus	0.00779	0.00779	CcSEcCtD
Clavulanate—Jaundice cholestatic—Irbesartan—type 2 diabetes mellitus	0.00764	0.00764	CcSEcCtD
Clavulanate—Hepatitis—Repaglinide—type 2 diabetes mellitus	0.00746	0.00746	CcSEcCtD
Clavulanate—Leukopenia—Chlorpropamide—type 2 diabetes mellitus	0.00725	0.00725	CcSEcCtD
Clavulanate—Leukopenia—Tolazamide—type 2 diabetes mellitus	0.00725	0.00725	CcSEcCtD
Clavulanate—Jaundice cholestatic—Losartan—type 2 diabetes mellitus	0.00719	0.00719	CcSEcCtD
Clavulanate—Eosinophilia—Glimepiride—type 2 diabetes mellitus	0.00713	0.00713	CcSEcCtD
Clavulanate—Thrombophlebitis—Gliclazide—type 2 diabetes mellitus	0.00713	0.00713	CcSEcCtD
Clavulanate—Thrombocytopenia—Tolbutamide—type 2 diabetes mellitus	0.00712	0.00712	CcSEcCtD
Clavulanate—Erythema multiforme—Repaglinide—type 2 diabetes mellitus	0.00706	0.00706	CcSEcCtD
Clavulanate—Hepatitis—Rosiglitazone—type 2 diabetes mellitus	0.00705	0.00705	CcSEcCtD
Clavulanate—Erythema multiforme—Rosiglitazone—type 2 diabetes mellitus	0.00667	0.00667	CcSEcCtD
Clavulanate—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.00654	0.00654	CcSEcCtD
Clavulanate—Thrombocytopenia—Tolazamide—type 2 diabetes mellitus	0.00647	0.00647	CcSEcCtD
Clavulanate—Thrombocytopenia—Chlorpropamide—type 2 diabetes mellitus	0.00647	0.00647	CcSEcCtD
Clavulanate—Swelling—Valsartan—type 2 diabetes mellitus	0.00642	0.00642	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Glimepiride—type 2 diabetes mellitus	0.00636	0.00636	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Sitagliptin—type 2 diabetes mellitus	0.00634	0.00634	CcSEcCtD
Clavulanate—Thrombocytopenia—Acarbose—type 2 diabetes mellitus	0.00622	0.00622	CcSEcCtD
Clavulanate—Hepatitis—Glipizide—type 2 diabetes mellitus	0.00617	0.00617	CcSEcCtD
Clavulanate—Jaundice cholestatic—Ramipril—type 2 diabetes mellitus	0.00616	0.00616	CcSEcCtD
Clavulanate—Hepatitis—Pioglitazone—type 2 diabetes mellitus	0.00592	0.00592	CcSEcCtD
Clavulanate—Eosinophilia—Glyburide—type 2 diabetes mellitus	0.00588	0.00588	CcSEcCtD
Clavulanate—Leukopenia—Repaglinide—type 2 diabetes mellitus	0.00582	0.00582	CcSEcCtD
Clavulanate—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.00577	0.00577	CcSEcCtD
Clavulanate—Hepatitis—Glimepiride—type 2 diabetes mellitus	0.00576	0.00576	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Gliclazide—type 2 diabetes mellitus	0.00555	0.00555	CcSEcCtD
Clavulanate—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00553	0.00553	CcSEcCtD
Clavulanate—Swelling—Irbesartan—type 2 diabetes mellitus	0.00552	0.00552	CcSEcCtD
Clavulanate—Leukopenia—Rosiglitazone—type 2 diabetes mellitus	0.0055	0.0055	CcSEcCtD
Clavulanate—Erythema multiforme—Glimepiride—type 2 diabetes mellitus	0.00545	0.00545	CcSEcCtD
Clavulanate—Erythema multiforme—Sitagliptin—type 2 diabetes mellitus	0.00543	0.00543	CcSEcCtD
Clavulanate—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.0053	0.0053	CcSEcCtD
Clavulanate—Urticaria—Tolazamide—type 2 diabetes mellitus	0.00525	0.00525	CcSEcCtD
Clavulanate—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.00525	0.00525	CcSEcCtD
Clavulanate—Urticaria—Linagliptin—type 2 diabetes mellitus	0.0052	0.0052	CcSEcCtD
Clavulanate—Swelling—Losartan—type 2 diabetes mellitus	0.00519	0.00519	CcSEcCtD
Clavulanate—Thrombocytopenia—Repaglinide—type 2 diabetes mellitus	0.00519	0.00519	CcSEcCtD
Clavulanate—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00514	0.00514	CcSEcCtD
Clavulanate—Rash—Miglitol—type 2 diabetes mellitus	0.0051	0.0051	CcSEcCtD
Clavulanate—Hypokalaemia—Orlistat—type 2 diabetes mellitus	0.0051	0.0051	CcSEcCtD
Clavulanate—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00509	0.00509	CcSEcCtD
Clavulanate—Urticaria—Acarbose—type 2 diabetes mellitus	0.00505	0.00505	CcSEcCtD
Clavulanate—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.00501	0.00501	CcSEcCtD
Clavulanate—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	0.00491	0.00491	CcSEcCtD
Clavulanate—Urticaria—Nateglinide—type 2 diabetes mellitus	0.00487	0.00487	CcSEcCtD
Clavulanate—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00482	0.00482	CcSEcCtD
Clavulanate—Leukopenia—Glipizide—type 2 diabetes mellitus	0.00481	0.00481	CcSEcCtD
Clavulanate—Nausea—Miglitol—type 2 diabetes mellitus	0.0048	0.0048	CcSEcCtD
Clavulanate—Hepatitis—Glyburide—type 2 diabetes mellitus	0.00475	0.00475	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Gliclazide—type 2 diabetes mellitus	0.00471	0.00471	CcSEcCtD
Clavulanate—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00468	0.00468	CcSEcCtD
Clavulanate—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00468	0.00468	CcSEcCtD
Clavulanate—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00468	0.00468	CcSEcCtD
Clavulanate—Rash—Tolbutamide—type 2 diabetes mellitus	0.00458	0.00458	CcSEcCtD
Clavulanate—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00452	0.00452	CcSEcCtD
Clavulanate—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00451	0.00451	CcSEcCtD
Clavulanate—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.00449	0.00449	CcSEcCtD
Clavulanate—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00448	0.00448	CcSEcCtD
Clavulanate—Hypokalaemia—Irbesartan—type 2 diabetes mellitus	0.00443	0.00443	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Irbesartan—type 2 diabetes mellitus	0.00439	0.00439	CcSEcCtD
Clavulanate—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00435	0.00435	CcSEcCtD
Clavulanate—Convulsion—Glimepiride—type 2 diabetes mellitus	0.00435	0.00435	CcSEcCtD
Clavulanate—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00433	0.00433	CcSEcCtD
Clavulanate—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00432	0.00432	CcSEcCtD
Clavulanate—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.00429	0.00429	CcSEcCtD
Clavulanate—Hepatitis—Gliclazide—type 2 diabetes mellitus	0.00427	0.00427	CcSEcCtD
Clavulanate—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00421	0.00421	CcSEcCtD
Clavulanate—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.0042	0.0042	CcSEcCtD
Clavulanate—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.0042	0.0042	CcSEcCtD
Clavulanate—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00419	0.00419	CcSEcCtD
Clavulanate—Rash—Tolazamide—type 2 diabetes mellitus	0.00417	0.00417	CcSEcCtD
Clavulanate—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00417	0.00417	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Losartan—type 2 diabetes mellitus	0.00413	0.00413	CcSEcCtD
Clavulanate—Rash—Linagliptin—type 2 diabetes mellitus	0.00413	0.00413	CcSEcCtD
Clavulanate—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00412	0.00412	CcSEcCtD
Clavulanate—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00409	0.00409	CcSEcCtD
Clavulanate—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00408	0.00408	CcSEcCtD
Clavulanate—Vomiting—Acarbose—type 2 diabetes mellitus	0.00404	0.00404	CcSEcCtD
Clavulanate—Erythema multiforme—Gliclazide—type 2 diabetes mellitus	0.00403	0.00403	CcSEcCtD
Clavulanate—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.00401	0.00401	CcSEcCtD
Clavulanate—Rash—Acarbose—type 2 diabetes mellitus	0.00401	0.00401	CcSEcCtD
Clavulanate—Dermatitis—Acarbose—type 2 diabetes mellitus	0.004	0.004	CcSEcCtD
Clavulanate—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00398	0.00398	CcSEcCtD
Clavulanate—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.00394	0.00394	CcSEcCtD
Clavulanate—Nausea—Tolazamide—type 2 diabetes mellitus	0.00393	0.00393	CcSEcCtD
Clavulanate—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00393	0.00393	CcSEcCtD
Clavulanate—Eosinophilia—Losartan—type 2 diabetes mellitus	0.00392	0.00392	CcSEcCtD
Clavulanate—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00392	0.00392	CcSEcCtD
Clavulanate—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.00392	0.00392	CcSEcCtD
Clavulanate—Hepatitis—Valsartan—type 2 diabetes mellitus	0.00392	0.00392	CcSEcCtD
Clavulanate—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00391	0.00391	CcSEcCtD
Clavulanate—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00389	0.00389	CcSEcCtD
Clavulanate—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.00389	0.00389	CcSEcCtD
Clavulanate—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.00387	0.00387	CcSEcCtD
Clavulanate—Hepatitis—Orlistat—type 2 diabetes mellitus	0.00387	0.00387	CcSEcCtD
Clavulanate—Rash—Nateglinide—type 2 diabetes mellitus	0.00386	0.00386	CcSEcCtD
Clavulanate—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00386	0.00386	CcSEcCtD
Clavulanate—Nausea—Acarbose—type 2 diabetes mellitus	0.00377	0.00377	CcSEcCtD
Clavulanate—Pain—Glipizide—type 2 diabetes mellitus	0.00375	0.00375	CcSEcCtD
Clavulanate—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00375	0.00375	CcSEcCtD
Clavulanate—Leukopenia—Glyburide—type 2 diabetes mellitus	0.0037	0.0037	CcSEcCtD
Clavulanate—Nausea—Nateglinide—type 2 diabetes mellitus	0.00364	0.00364	CcSEcCtD
Clavulanate—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00363	0.00363	CcSEcCtD
Clavulanate—Convulsion—Glyburide—type 2 diabetes mellitus	0.00358	0.00358	CcSEcCtD
Clavulanate—Hepatitis—Metformin—type 2 diabetes mellitus	0.00357	0.00357	CcSEcCtD
Clavulanate—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00355	0.00355	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.00354	0.00354	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.0035	0.0035	CcSEcCtD
Clavulanate—Pain—Sitagliptin—type 2 diabetes mellitus	0.00349	0.00349	CcSEcCtD
Clavulanate—Urticaria—Glipizide—type 2 diabetes mellitus	0.00348	0.00348	CcSEcCtD
Clavulanate—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00343	0.00343	CcSEcCtD
Clavulanate—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00337	0.00337	CcSEcCtD
Clavulanate—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.00337	0.00337	CcSEcCtD
Clavulanate—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.00336	0.00336	CcSEcCtD
Clavulanate—Rash—Repaglinide—type 2 diabetes mellitus	0.00334	0.00334	CcSEcCtD
Clavulanate—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00334	0.00334	CcSEcCtD
Clavulanate—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00334	0.00334	CcSEcCtD
Clavulanate—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00332	0.00332	CcSEcCtD
Clavulanate—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00331	0.00331	CcSEcCtD
Clavulanate—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00325	0.00325	CcSEcCtD
Clavulanate—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00324	0.00324	CcSEcCtD
Clavulanate—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00323	0.00323	CcSEcCtD
Clavulanate—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00322	0.00322	CcSEcCtD
Clavulanate—Hepatitis—Losartan—type 2 diabetes mellitus	0.00317	0.00317	CcSEcCtD
Clavulanate—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00316	0.00316	CcSEcCtD
Clavulanate—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00316	0.00316	CcSEcCtD
Clavulanate—Nausea—Repaglinide—type 2 diabetes mellitus	0.00315	0.00315	CcSEcCtD
Clavulanate—Pruritus—Glipizide—type 2 diabetes mellitus	0.0031	0.0031	CcSEcCtD
Clavulanate—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.0031	0.0031	CcSEcCtD
Clavulanate—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00302	0.00302	CcSEcCtD
Clavulanate—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00301	0.00301	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.003	0.003	CcSEcCtD
Clavulanate—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.003	0.003	CcSEcCtD
Clavulanate—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.003	0.003	CcSEcCtD
Clavulanate—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00298	0.00298	CcSEcCtD
Clavulanate—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00297	0.00297	CcSEcCtD
Clavulanate—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00293	0.00293	CcSEcCtD
Clavulanate—Convulsion—Orlistat—type 2 diabetes mellitus	0.00292	0.00292	CcSEcCtD
Clavulanate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.0029	0.0029	CcSEcCtD
Clavulanate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00288	0.00288	CcSEcCtD
Clavulanate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.0028	0.0028	CcSEcCtD
Clavulanate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00279	0.00279	CcSEcCtD
Clavulanate—Vomiting—Glipizide—type 2 diabetes mellitus	0.00279	0.00279	CcSEcCtD
Clavulanate—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00279	0.00279	CcSEcCtD
Clavulanate—Rash—Glipizide—type 2 diabetes mellitus	0.00277	0.00277	CcSEcCtD
Clavulanate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00276	0.00276	CcSEcCtD
Clavulanate—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00275	0.00275	CcSEcCtD
Clavulanate—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00273	0.00273	CcSEcCtD
Clavulanate—Hepatitis—Ramipril—type 2 diabetes mellitus	0.00272	0.00272	CcSEcCtD
Clavulanate—Urticaria—Glyburide—type 2 diabetes mellitus	0.00268	0.00268	CcSEcCtD
Clavulanate—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00263	0.00263	CcSEcCtD
Clavulanate—Nausea—Glipizide—type 2 diabetes mellitus	0.00261	0.00261	CcSEcCtD
Clavulanate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.0026	0.0026	CcSEcCtD
Clavulanate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00259	0.00259	CcSEcCtD
Clavulanate—Pain—Gliclazide—type 2 diabetes mellitus	0.00259	0.00259	CcSEcCtD
Clavulanate—Rash—Glimepiride—type 2 diabetes mellitus	0.00258	0.00258	CcSEcCtD
Clavulanate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00258	0.00258	CcSEcCtD
Clavulanate—Rash—Sitagliptin—type 2 diabetes mellitus	0.00257	0.00257	CcSEcCtD
Clavulanate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00257	0.00257	CcSEcCtD
Clavulanate—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.00257	0.00257	CcSEcCtD
Clavulanate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00253	0.00253	CcSEcCtD
Clavulanate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00249	0.00249	CcSEcCtD
Clavulanate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.00248	0.00248	CcSEcCtD
Clavulanate—Leukopenia—Losartan—type 2 diabetes mellitus	0.00247	0.00247	CcSEcCtD
Clavulanate—Nausea—Glimepiride—type 2 diabetes mellitus	0.00243	0.00243	CcSEcCtD
Clavulanate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00242	0.00242	CcSEcCtD
Clavulanate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00241	0.00241	CcSEcCtD
Clavulanate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00239	0.00239	CcSEcCtD
Clavulanate—Pruritus—Glyburide—type 2 diabetes mellitus	0.00239	0.00239	CcSEcCtD
Clavulanate—Pain—Orlistat—type 2 diabetes mellitus	0.00235	0.00235	CcSEcCtD
Clavulanate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00235	0.00235	CcSEcCtD
Clavulanate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00234	0.00234	CcSEcCtD
Clavulanate—Rash—Bromocriptine—type 2 diabetes mellitus	0.00233	0.00233	CcSEcCtD
Clavulanate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00233	0.00233	CcSEcCtD
Clavulanate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00231	0.00231	CcSEcCtD
Clavulanate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00225	0.00225	CcSEcCtD
Clavulanate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00223	0.00223	CcSEcCtD
Clavulanate—Urticaria—Valsartan—type 2 diabetes mellitus	0.00221	0.00221	CcSEcCtD
Clavulanate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00221	0.00221	CcSEcCtD
Clavulanate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00219	0.00219	CcSEcCtD
Clavulanate—Urticaria—Orlistat—type 2 diabetes mellitus	0.00219	0.00219	CcSEcCtD
Clavulanate—Vomiting—Glyburide—type 2 diabetes mellitus	0.00215	0.00215	CcSEcCtD
Clavulanate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00214	0.00214	CcSEcCtD
Clavulanate—Rash—Glyburide—type 2 diabetes mellitus	0.00213	0.00213	CcSEcCtD
Clavulanate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00213	0.00213	CcSEcCtD
Clavulanate—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00212	0.00212	CcSEcCtD
Clavulanate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00207	0.00207	CcSEcCtD
Clavulanate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00205	0.00205	CcSEcCtD
Clavulanate—Convulsion—Ramipril—type 2 diabetes mellitus	0.00205	0.00205	CcSEcCtD
Clavulanate—Pain—Irbesartan—type 2 diabetes mellitus	0.00205	0.00205	CcSEcCtD
Clavulanate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00203	0.00203	CcSEcCtD
Clavulanate—Urticaria—Metformin—type 2 diabetes mellitus	0.00201	0.00201	CcSEcCtD
Clavulanate—Nausea—Glyburide—type 2 diabetes mellitus	0.00201	0.00201	CcSEcCtD
Clavulanate—Pruritus—Valsartan—type 2 diabetes mellitus	0.00197	0.00197	CcSEcCtD
Clavulanate—Pruritus—Orlistat—type 2 diabetes mellitus	0.00195	0.00195	CcSEcCtD
Clavulanate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00193	0.00193	CcSEcCtD
Clavulanate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00193	0.00193	CcSEcCtD
Clavulanate—Pain—Losartan—type 2 diabetes mellitus	0.00193	0.00193	CcSEcCtD
Clavulanate—Rash—Gliclazide—type 2 diabetes mellitus	0.00191	0.00191	CcSEcCtD
Clavulanate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00191	0.00191	CcSEcCtD
Clavulanate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00191	0.00191	CcSEcCtD
Clavulanate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.0019	0.0019	CcSEcCtD
Clavulanate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.00189	0.00189	CcSEcCtD
Clavulanate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00188	0.00188	CcSEcCtD
Clavulanate—Nausea—Gliclazide—type 2 diabetes mellitus	0.0018	0.0018	CcSEcCtD
Clavulanate—Pruritus—Metformin—type 2 diabetes mellitus	0.00179	0.00179	CcSEcCtD
Clavulanate—Urticaria—Losartan—type 2 diabetes mellitus	0.00179	0.00179	CcSEcCtD
Clavulanate—Vomiting—Valsartan—type 2 diabetes mellitus	0.00177	0.00177	CcSEcCtD
Clavulanate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Clavulanate—Rash—Valsartan—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Clavulanate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00175	0.00175	CcSEcCtD
Clavulanate—Vomiting—Orlistat—type 2 diabetes mellitus	0.00175	0.00175	CcSEcCtD
Clavulanate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Clavulanate—Rash—Orlistat—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Clavulanate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00173	0.00173	CcSEcCtD
Clavulanate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00169	0.00169	CcSEcCtD
Clavulanate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Clavulanate—Nausea—Valsartan—type 2 diabetes mellitus	0.00165	0.00165	CcSEcCtD
Clavulanate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Clavulanate—Nausea—Orlistat—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Clavulanate—Vomiting—Metformin—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Clavulanate—Rash—Metformin—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Clavulanate—Dermatitis—Metformin—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Clavulanate—Pruritus—Losartan—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Clavulanate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00154	0.00154	CcSEcCtD
Clavulanate—Urticaria—Ramipril—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Clavulanate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Clavulanate—Rash—Irbesartan—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Clavulanate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Clavulanate—Nausea—Metformin—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Clavulanate—Vomiting—Losartan—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Clavulanate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Clavulanate—Nausea—Irbesartan—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Clavulanate—Rash—Losartan—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Clavulanate—Dermatitis—Losartan—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Clavulanate—Pruritus—Ramipril—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Clavulanate—Nausea—Losartan—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Clavulanate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Clavulanate—Vomiting—Ramipril—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Clavulanate—Rash—Ramipril—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Clavulanate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Clavulanate—Nausea—Ramipril—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
